A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab-Reference-Cited by-同舟云学术

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

Published:2016-12 Issue: Volume:Volume 13 Page:33-40
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Affronti Mary Lou,Woodring Sarah,Peters Katherine B,Herndon II James E,McSherry Frances,Healy Patrick N,Desjardins Annick,Vredenburgh James J,Friedman Henry S

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens;Journal of Cancer Research and Clinical Oncology;2021-07-24

2. Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide;Supportive Care in Cancer;2019-08-22

3. Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors;Clinical Journal of Oncology Nursing;2019-01-25

4. Brain Tumor Rehabilitation;Central Nervous System Cancer Rehabilitation;2019

5. Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis;Oncotarget;2017-04-24